Integrating Science And Computational Talent
Source: Cytiva
Compute specialists and traditional scientists speak different languages, but to effectively deploy and benefit from computational biology technologies, they need to gel. During our Bioprocess Online Live event, How Computational Biology Speeds Drug Discovery, Development, Tina Larson, President and COO at Recursion, and Andrew Satz, CEO and Co-Founder at EVQLV, shared best practices on how to get the holders of seemingly disparate intellectual property to collaborate effectively.
access the Video!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.
Subscribe to Bioprocess Online
X
Subscribe to Bioprocess Online
Cytiva
This website uses cookies to ensure you get the best experience on our website. Learn more